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Abstract 
Background: Previous work found that urea accumulation in urothelial cells caused by urea transporter B knockout 
led to DNA damage and apoptosis that contributed to the carcinogenesis. The purpose of this study is to explore the 
potential connection between high urinary urea concentration and the bladder disorders.
Methods: A high protein diet rat model was conducted by feeding with 40 % protein diet. In-silico modeling and 
algorithm, based on the results of microarray and proteomics from the bladder urothelium, were used for the recon-
struction of accurate cellular networks and the identification of novel master regulators in the high-protein diet rat 
model. Pathway and biological process enrichment analysis were used to characterize predicted targets of candi-
date mRNAs/proteins. The expression pattern of the most significant master regulators was evaluated by qPCR and 
immunohistochemistry.
Results: Based on the analysis of different expressed mRNAs/proteins, 15 significant ones (CRP, MCPT2, MCPT9, 
EPXH2, SERPING1, SRGN, CDKN1C, CDK6, CCNB1, PCNA, BAX, MAGEB16, SERPINE1, HSPA2, FOS) were highly identified 
and verified by qPCR and immunohistochemistry. They were involved in immune and inflammatory response, cell 
cycle arrest, apoptosis and pathways in cancer. These abnormally activated processes caused the bladder interstitial 
congestion and inflammatory infiltrates under the thinner urothelium, cell desquamation, cytoplasm vacuolization, 
nucleus swelling and malformation in the high-protein diet group.
Conclusions: We provided evidences that high urinary urea concentration caused by high-protein diet might be a 
potential carcinogenic factor in bladder.
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Background
As a malignant tumor of the urinary tract, urothe-
lial bladder cancer (UBC) is the seventh most common 
malignancy in men and the seventeenth most com-
mon in women worldwide [1]. Globally each year, more 
than 400,000 new patients are diagnosed with bladder 
cancer and more than 150,000 patients die from it [2]. 
The survival rate of bladder cancer is poor, with almost 
45  % of patients surviving for 5  years regardless of the 
type of treatment [3]. This heterogeneous disease has 
complex pathological mechanisms that are not yet fully 
expounded. So far, although it has been suggested that 
the risk of the disease is associated with many induce-
ments including cigarette smoking, alcohol, drugs, chem-
ical carcinogens and inflammation of the urinary tract, 
etc. [4], the exact causes of UBC have not been clarified 
[5].
Recent years, epidemiological studies showed that the 
incidence of the bladder cancer was the highest in the 
developed countries of Western Europe, North America 




*Correspondence:  baoxue@bjmu.edu.cn 
1 State Key Laboratory of Natural and Biomimetic Drugs, Department 
of Pharmacology, School of Basic Medical Sciences, Peking University, 38 
Xueyuan Lu, Haidian District, Beijing 100191, China
Full list of author information is available at the end of the article
Page 2 of 17Liu et al. J Transl Med  (2016) 14:53 
may be connected with their different diets and living 
habits. Meanwhile, results from genome-wide association 
studies (GWAS) had identified the urea transporter B 
(UT-B) gene (solute carrier family 14, member 1, slc14a1) 
as a new bladder cancer susceptibility locus in human [7, 
8]. UT-B plays an important role in urine concentrating 
mechanism and it highly expresses in the urinary bladder 
urothelium [9, 10]. As far as we know, whether slc14a1 
variants had a direct effect on the urothelium or, possi-
bly, the association with UBC was indirect through urine 
concentration or frequency of urination was not explicit 
yet [7]. An our previous study found that UT-B knockout 
caused urea accumulation in the bladder urothelial cells, 
which created an imbalance between the arginine-ornith-
ine-polyamine pathway and the arginine-citrulline-nitric 
oxide pathway. These processes thus rendered urothelial 
cells more vulnerable to DNA damage and apoptosis that 
contributed to the bladder carcinogenesis [11]. These 
findings suggest that high urea concentration may serve 
as a potential pathogenic factor. Urea is a major nitrog-
enous waste product of protein metabolism. High-pro-
tein diet increases the urea concentration in urine, which 
makes us explore whether the continuous high urea stim-
ulation could damage the urothelium and then increase 
the risk of carcinogenesis.
Here, using a high-protein diet rat model and a net-
work-based strategy, it is found that high urinary urea 
concentration activated pathways including inflamma-
tory response, cell cycle arrest, apoptosis and cancer in 
urothelium of rats with high-protein diet. These find-
ings suggest a potential connection between high uri-




All procedures in this study were carried out in strict 
accordance with the recommendations in the guide for 
the care and use of Laboratory Animals of China Associ-
ation for Laboratory Animal Science. All animal care and 
protocols were approved by the Animal Care Committee 
of Peking University Health Science Center. All sacrifice 
was performed under pentobarbitone anesthesia, and 
every effort was made to minimize animal suffering.
Animal model with high urea concentration and osmolality 
in the bladder
High-protein diet rat model in strictly controlled urine 
concentrating ability: Adult male SD rats (3 rats/group, 
body weight 160–180 g) were adapted in metabolic cages 
(Harvard Apparatus, Holliston, MA) for 3  days and 
fed with a standard synthetic rodent diet (20  % protein 
in diet). From day 4 to 7, the rats were fed with a diet 
with 40  % protein or 10  % protein in the high-protein 
diet group (HPD) or the low-protein diet group (LPD), 
respectively. In order to amplify the effects of urea con-
centration on the urothelial cells between the two groups, 
3.5 μg/kg/12 h of dDAVP (1-deamino-8-D-arginine vaso-
pressin), which could increase the absorption of water in 
the collecting duct and lead to a high urea concentration 
in the bladder, was administrated by subcutaneous injec-
tion in the HPD group and 10 ml/12 h water was intra-
peritoneally injected in LPD group from day 8 to 12.
High-protein diet rat model in normal urine concen-
trating ability: Adult male SD rats (6 rats/group, body 
weight 160–180 g) were separated into two groups: rats 
were fed with 40  % protein diet or 20  % protein diet in 
the HPD group or the normal-protein diet group (NPD) 
respectively for 40 days. In this model it made the urothe-
lial cells of the HPD group suffer in a high urea concen-
tration environment for a long time. During the whole 
study, the rats in the two models had free access to water 
and food.
The urinary osmolality was measured by freezing point 
depression (Micro-osmometer, FISKER ASSOCIATES, 
Norwood, MA). Urea concentration was measured with 
QuantiChrom Urea Assay kit (BioAssay Systems, Hay-
ward, CA).
Microarray analysis
Rat was deeply anesthetized with pentobarbital (85 mg/
kg, i.p.) and the bladder was removed and cut into two 
parts. One was used for microarray analysis and the 
other was used for proteomics analysis. The urothelial 
cells were harvested by gently scraping the urothelium 
of bladder using a knife. Total RNA of the two groups 
was isolated with the RNA easy Isolation Kit (Qiagen). 
All RNA samples used in this experiment were of high 
quality as indicated by a ratio of 2:1 for 28S/18S rRNA 
and a ratio of >1.9 for OD260/OD280. The gene expression 
profiles were determined using GeneChip® rat Gene 2.0 
ST Arrays (Affymetrix). Samples were hybridized onto 
array chips according to Affymetrix protocol. The chips 
were washed and stained in a GeneChip Fluidics Station 
450 and fluorescence detected with a GeneChip Scan-
ner 3000 7G using the Affymetrix GeneChip Operating 
Software. Differentially expressed genes were identified 
as fold change ≥1.5 and P value <0.01 by unpaired t-test.
Proteomics analysis
Protein sample preparation including extraction, quan-
tification and filter aided sample preparation (FASP) 
was according to the recommendations detailed in the 
iTRAQ kit (AB Sciex). Peptides were labeled with respec-
tive isobaric tags of 4-plex iTRAQ Reagent Multi-Plex kit 
(AB Sciex, PN: 4352135) according to the manufacturer 
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supplied protocol (Applied Biosystems, MA, USA). 
Reverse phase LC-MS/MS analyzed using Thermo Scien-
tific EASY-nLC 1000 System (Nano HPLC) and the raw 
data processed using Proteome Discoverer 1.3 Software. 
Proteins with a fold change ≥1.2 were considered signifi-
cant as P value <0.01 and the false discovery rates (FDR) 
<0.01.
Construction and analysis of protein–protein interaction 
(PPI) network
The PPI is considered as a basic skeleton for analysis of 
living organism self-organization and homeostasis [12]. 
Changed mRNA expressions and protein expressions 
based on the results of microarray and proteomics in 
high-protein diet rat model with strictly controlled urine 
concentrating ability were considered as the seed mol-
ecules, from which we obtained two direct and indirect 
PPIs using Bisogenet [13], a cytoscape [14] plugin. This 
method allows searching molecular interactions from 
well-known interaction databases including the Database 
of Interacting Proteins (DIP), the General Repository for 
Interaction Datasets (BIOGRID), the Human Protein 
Reference Database (HPRD), the Biomolecular Interac-
tion Network Database (BIND), the Molecular Interac-
tions Database (MINT) and the Database system and 
analysis tools for protein interaction data (IntAct)[15]. 
Then an intersection sub-network with nodes and edges 
merged by the two networks was obtained using the 
Advanced Network Merge plugin. In this network, each 
node represents a gene/protein and edge stands for the 
interaction between the two nodes.
Identification of functional modules in the network
Clusters in a PPI network are often protein complexes 
and parts of pathways, while clusters in a protein similar-
ity network represent protein families [16]. The Molecu-
lar Complex Detection (MCODE) [17] effectively finds 
closely connected regions of a molecular interaction 
network, many of which correspond to known molecu-
lar complexes, based solely on connectivity data. In this 
study, we used the MCODE to identify the functional 
modules with the degree cut-off  =  2, K-core  =  2 and 
Max.depth  =  100. Six highly connected modules with 
smallest P value were detected.
Functional enrichment analysis of the network
Intersection network and modules analysis: the KEGG 
(Kyoto Encyclopedia of Genes and Genomes) path-
way enrichment and the gene ontology (GO) func-
tional enrichment analysis were performed by using 
the online tool DAVID (Database for Annotation, Visu-
alization, and Integrated Discovery) [18] based on the 
“KEGG_PATHWAY” and ‘‘GOTERM_BP_FAT’’ options. 
The terms only with P value <0.01 and FDR <0.05 were 
selected.
Analysis of the changed mRNAs and proteins: to fur-
ther understand the biological relevance between the 
changed mRNAs or proteins and their regulators in the 
intersection sub-network, we performed functional 
enrichment analysis of these 106 changed mRNAs/pro-
teins using Bingo [19], a plugin of the cytoscape.
RT‑qPCR
Total RNA of rat bladder urothelium was isolated by 
homogenization in TRIzol reagent (Invitrogen, Carlsbad, 
CA), cDNA was reverse transcribed from mRNA accord-
ing to the instructions of RevertAid First Strand cDNA 
Synthesis Kit (Invitrogen). SyBR Green was used for 
fluorescence detection and real-time qPCR was carried 
out on Mxpro system. The specific mRNA amount was 
normalized by the β-actin amount from the same cDNA 
sample.
The primers used were as follows: EPHX2, F: 5′-CCTAC 
TTGGCGCTTTCCAGAT-3′, R: 5′-GCAGCTTTCATCC 
ATGAGTGG-3′; CDKN1C, F: 5′-AGAACAAGGCGTCG 
AACGAT-3′, R: 5′-GCAAGTTCTCTCTGGCCGTT-3′; 
CDK6, F: 5′-AGTGTTGGCTGCATCTTTGC-3′, R: 5′-C 
CTGTCTGGGAAGAGCAACA-3′; PCNA, F: 5′-AGA 
GCATGGATTCGTCTCACG-3′, R: 5′-TGGACATGCT 
GGTGAGGTTC-3′; BAX, F: 5′-TGGCGATGAACTGGA 
CAACA-3′, R: 5′-CAGTTGAAGTTGCCGTCTGC-3′; 
MAGEB16, F: 5′-GCCAAGGTTCATGGGTCAGA-3′, R: 
5′-CTCGGGCCAGCTTGTTCTAA-3′; SERPINE1, F:5′- 
CGTCTTCCTCCACAGCCATT-3′, R: 5′-GCTGGCC 
CATGAAGAGGATT-3′; HSPA2, F: 5′-CCTAACGTTG 
CTTTGCCTGT-3′, R: 5′-CACCTTGCCATGTTGGAAG 
AC-3′; FOS, F: 5′-AGACGAGAAGTCTGCGTTGC-3′, 
R: 5′-TCCAGGGAGGTCACAGACAT-3′; CRP, F: 5′-GC 
CTTCGTATTTCCCGGAGT-3′, R: 5′-ACATCAGCGTG 
GGCATAGAG-3′; SERPING1 F: 5′-CGTGGCCCGAA 
ACTTACTCA-3′, R: 5′-TGGCAGTGCTTACTCAAGC 
C-3′; SRGN, F: 5′-GTTCAAGGTTATCCTGCTCGG 
A-3′, R: 5′-GGAAGAAATCATTCGGGAATCCTC-3′; 
MCPT9, F: 5′-ATTCCGGTTGGCCTGTCCTA-3′, R: 
5′-TCTCGTGAGGTTTGGCCTTT-3′; CCNB1, F: 5′-TC 
CCACACGGAGGAATCTCT-3′, R: 5′-TCTGCAGA 
CGAGGTAGTCCA-3′; MCPT2, F: 5′-TCCCACAACTT 
TAAGAGCAGCA-3′, R: 5′-TGGAGACTCGGGTGAAG 
ATTG-3′.
Histology and immunohistochemistry
4  % paraformaldehyde-fixed and paraffin-embed-
ded rat bladders were sectioned at a thickness of 
6-μm and stained with hematoxylin and eosin. 
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Immunohistochemistry was performed using standard 
methods. Briefly, the slides were dried at 60  °C for 2  h 
and deparaffinized in xylene. Endogenous peroxidase 
activity was eliminated by 3 % H2O2 in ddH2O and anti-
gen was retrieved by citric acid buffer (pH 6.0) for 10 min 
at 95 °C. The sections were blocked with 5 % (w/v) goat 
serum albumin for 30  min at room temperature. Pri-
mary antibodies (BAX, SANTA, 1:50 dilution; PCNA, 
CST, 1:100 dilution; F4/80, CST, 1:100 dilution; C-FOS, 
CyclinB1, P27, PAI-1, Ruiying Biological, 1:100 dilution) 
were applied and incubated overnight at 4 °C followed by 
secondary antibody (Scicrest Biotech, 1:200) for 30  min 
at 37  °C. Diaminobenzidene (DAB, ZLI-9018, Zhong 
Shan Jin Qiao) was employed for 5 min as the chromo-
gen. The numbers of positive cells or relative intensity in 
5 sections per mouse from 6 mice were quantitated and 
averaged by Image Pro Plus 6.0 software.
Statistical analyses
All results were represented as mean  ±  SEM. Data 
involving in two groups was analyzed using two-tailed 
student t-test. When more than two experimental groups 
were compared, the data was analyzed using the Tukey-
Kramer test with Prism 5.0 software to compare data 
between individual groups. P value <0.05 was considered 
to be statistically significant.
Results
Diet protein amount regulated urinary urea concentration 
and osmolality
In rats fed with high-protein diet and treated with 
dDAVP, urea was highly concentrated in urine up to 
more than 2600 mmol/l, meanwhile, the urine osmolality 
was increased to almost 3000 mOsm/kg H2O (Fig. 1a, b). 
In rats fed with low-protein diet and treated with water, 
urinary urea concentration was decreased to approxi-
mately 150  mmol/l and urine osmolality decreased to 
around 700 mOsm/kg H2O. The urinary urea and osmo-
lality in the high-protein diet group were almost 17- and 
4-folds higher than those in the low-protein diet group, 
respectively.
Diet protein amount regulated mRNA and protein 
expression in urothelium
Microarray and proteomics analysis of rat bladder 
urothelium showed levels of 521 mRNAs and 199 pro-
teins changed in rats fed with different protein diet. 
These altered mRNAs and proteins were considered as 
the seed molecules, from which we obtained two PPI 
networks using Bisogenet, a Cytoscape plugin. There 
were 3264 nodes with 55,258 edges in the first network 
and 2470 nodes with 41,273 edges in the second network 
constructed by the results of microarray and proteomics, 
respectively (Fig. 1c). Then using the Advanced Network 
Merge plugin, an intersection sub-network with 1297 
nodes and 2597 edges was obtained (Fig.  1d). Among 
these 1297 nodes, 106 nodes including 59 mRNAs (28 
up-regulated and 31 down-regulated) significantly 
changed in the microarray and 67 proteins (47 up-reg-
ulated and 20 down-regulated) significantly changed in 
the proteomics, respectively, (20 nodes including FLNA, 
TTR, S100A4, TPM2, DES, C3, FGB, TAGLN, HBB, 
MSLN, CNN1, MYL9, EPHX2, ALDH3A1, MCPT9, 
MCPT2, MAGEB16, TSPAN8, AKR1B8, OCM were sig-
nificantly changed in both), were considered as the signif-
icant mRNAs/proteins (Table 1). We mapped the nodes 
with high degree connectivity, analyzed by the network 
analyzer, to the large size with red color while the ones 
with low degree connectivity to the small size with green 
color inversely in Fig. 1e.
High‑protein diet regulated mRNAs/proteins expression 
involved in bladder disorders
To assess the predominant KEGG pathways and GO 
biological processes of this intersection network, we 
uploaded these 1297 mRNAs/proteins to the online bio-
logical classification tool DAVID and analyzed them 
based on the “KEGG_PATHWAY” and ‘‘GOTERM_BP_
FAT’’ options. As shown in Figs. 2, 3, most of the KEGG 
pathways and biological processes focused on pathways 
in cancer, cell apoptosis, cell death and cell cycle: 112 
mRNAs/proteins (9.67 %) were enriched in pathways in 
cancer with a fold enrichment score of 3.15; 49 mRNAs/
proteins (4.23  %) were enriched in cell cycle regulation 
with a fold enrichment score of 3.47 (Fig. 2); 162 mRNAs/
proteins (13.99 %) were enriched in cell death or apopto-
sis with a fold enrichment score of 2.86 (Fig. 3), etc.
To further identify the functional molecular complexes 
from this intersection sub-network, we employed a sta-
tistical approach of MCODE to cluster mRNAs/proteins. 
With degree >2, Degree Cut-off =  2, K-core =  2, Max.
depth = 100, six modules were screened out (Fig. 4a–f). 
Module A including one (FN1, Fig. 4a) of these 106 sig-
nificant mRNAs/proteins was focused on ribosome bio-
genesis; module B including five (ISG15, CDK6, HSPA2, 
SOX2, CALD1, Fig.  4b) mRNAs/proteins was focused 
on pathways in cancer, T cell receptor signaling path-
way, cell death and apoptosis; module C including eight 
(PCNA, SIN3A, FOS, KRT1, EEF1B2, IFIT3, APOE, 
HIST1H2AK, Fig.  4c) mRNAs/proteins and module D 
including one (ZBTB16, Fig.  4d) mRNA/protein were 
focused on pathways in cancer; module E and F including 
zero mRNA/protein was focused on cell cycle (Fig.  4e, 
f ) and inflammation (Fig. 4f ), data were not shown. This 
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Fig. 1 The levels of urea concentration, osmolality in urine and flow chart of network building. From day 1 to 3: normal diet with free access to water. 
Day 4–7: 40 or 10 % protein in diet in the high-protein diet group or low-protein diet, respectively. Day 8–12: 40 % protein in diet with 3.5 μg/kg/12 h of 
dDAVP injection in the HPD group and 10 % protein in diet with 10 ml/12 h water injection in the LPD group; a Urinary urea concentration. b Urinary 
osmolality. n = 6; Mean ± SEM.; *P < 0.05, **P < 0.01 and ***P < 0.001; NS stands for no significant. c Process of the combination of the two networks. d 
The intersection sub-network generated by the results of microarray and proteomics using Advanced Network Merge plugin. Pink nodes represent the 
seed molecules. Blue nodes stand for the interacting proteins generated by Bisogenet, based on the protein well-known interaction databases; e 106 
nodes contained in the microarray and proteomics were derived from the intersection sub-network and considered as significant mRNAs/proteins
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Table 1 106 significant genes/proteins in the intersection sub-network
Gene symbol Microarray (fold change) Proteomics (fold change) Degree Module
MCPT9 3.310011 1.510910 0
MCPT2 2.780586 1.801877 0
HBB 1.857657 1.367048 14
MAGEB16 1.841369 1.219194 0
TTR 1.738377 1.366377 50
ALDH3A1 1.523775 1.347139 4
EPHX2 1.513983 1.449821 5
FGB 1.512520 1.217485 19
FLNA 0.659427 1.428516 146
TSPAN8 0.655180 0.817315 0
TPM2 0.647158 1.677788 38
TAGLN 0.647115 1.387740 19
AKR1B8 0.636913 0.631030 0
MYL9 0.632688 1.244950 11
DES 0.596159 1.667755 37
OCM 0.546350 0.772013 0
MSLN 0.544640 0.617956 13
CNN1 0.537661 1.430010 13
S100A4 0.527200 0.800636 40
C3 0.349307 1.553393 32
SERPINE1 2.245071 1.130098 15
ISG15 2.228321 1.135855 81 B
SRGN 1.915938 1.123091 6
IFIT3 1.807260 – 35 C
HSPA2 1.740325 1.055071 27 B
SOX2 1.692999 1.085868 26 B
ZBTB16 1.684050 1.096661 60 F
CDKN1C 1.682264 1.124969 10
TPM1 1.647525 1.055467 45
NR1H3 1.632770 – 20
IRF7 1.598710 – 20
COL17A1 1.587436 1.115462 9
ADORA2A 1.558627 0.995801 9
EEF1B2 1.551863 0.984599 40 C
HIST1H2AK 1.536522 1.036648 23 C
FOS 1.524554 1.119582 72 C
BAX 1.520690 1.115530 33
HBG1 1.515075 – 10
NDUFA2 1.501249 1.047733 20
GDAP1 1.501249 1.025848 5
FN1 0.664729 0.944520 386 A
PARD6B 0.651307 0.881654 14
CCNB1 0.640989 0.920932 49
DIAPH3 0.634613 0.983113 11
SGOL2 0.634613 – 4
PRC1 0.629975 0.980930 9
ARHGEF6 0.629887 1.019215 23
UBA2 0.627761 – 36
LTBP1 0.605885 0.978378 11
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Table 1 continued
Gene symbol Microarray (fold change) Proteomics (fold change) Degree Module
PAPPA 0.601551 – 10
CDK6 0.600723 0.977918 37 B
PLN 0.584696 0.954198 4
AREG 0.580722 – 8
PRSS23 0.519846 – 12
SERPING1 0.513943 0.892042 9
FHL1 0.485693 1.198227 24
C2 0.477574 – 5
ACTC1 0.455956 0.967525 41
KRT14 0.453798 0.835215 36
KRT1 0.928397 2.156542 45 C
CRP 1.281350 1.930480 16
CALD1 0.698924 1.708044 17 B
KRT20 1.000797 1.659203 7
KRT10 1.000000 1.632362 41
PDE4DIP 0.951103 1.536384 21
DECR1 1.120752 1.427631 8
SYNM 0.723882 1.415602 9
SYNPO2 0.697342 1.405946 10
PDLIM7 0.876647 1.396267 27
MYLK 0.884821 1.386343 17
ACTA2 – 1.338323 47
CTSD 0.967471 1.325037 21
ZYX 1.000000 1.317850 62
NQO1 1.081580 1.313200 11
GC 1.104551 1.304363 10
ACAA1 – 1.300248 11
SLC4A1 0.968066 1.297543 10
FBN1 1.013898 1.287208 11
ALB 1.397036 1.266113 69
ACTN1 1.127086 1.262533 69
CFB – 1.259225 7
FGA 1.000000 1.249999 19
S100A1 1.328431 1.244232 16
FGG 1.050224 1.243389 9
SORBS1 – 1.240217 24
CTSC 1.108849 1.232253 6
AMBP 1.127504 1.224902 11
COL1A1 1.138096 1.224453 32
COL1A2 1.057467 1.220590 18
APOE 1.375960 1.214975 32 C
KRT5 – 1.204095 40
NOP58 0.860563 0.830641 47
SSB 0.969600 0.828536 49
B2M 0.941857 0.827784 13
TRIM21 1.222173 0.827560 40
CDC42 0.959164 0.821915 87
PDPK1 0.928232 0.817906 13
SIN3A 1.023062 0.800982 101 C
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clustering analysis further confirmed the activated bio-
logical processes from the KEGG pathway and GO analy-
sis of the intersection sub-network.
Besides, to biologically characterize these 106 significant 
mRNAs/proteins in the intersection sub-network (Fig. 1e), 
we analyzed them using the Cytoscape plugin BINGO. The 
Table 1 continued
Gene symbol Microarray (fold change) Proteomics (fold change) Degree Module
IDI1 0.842511 0.790994 3
CORO1B 0.898386 0.789598 16
GNE 0.914991 0.770752 6
EEF1A1 1.011713 0.769277 204 D
DNAJC7 0.993363 0.764110 21
PCNA 0.897037 0.748792 127 C
ORM1 0.864442 0.637926 7
CLU 0.848667 0.479796 50
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Fig. 2 KEGG pathways of the intersection sub-network. Bubble diagram of the over-represented KEGG pathways of the intersection sub-network in 
bladder urothelium associating with high-protein diet was mapped using stats package in R environment
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results revealed that these changed mRNAs/proteins had 
close relation with immune and inflammatory response 
(Fig. 5): 6 mRNAs/proteins (5.8 %) were enriched in com-
plement activation, immune effector process and humoral 
immune response with a fold enrichment score of 26.49, 
25.71 and 19.00 respectively, 9 mRNAs/proteins (8.7  %) 
were enriched in acute inflammatory response with a fold 
enrichment score of 14.57, etc.
Overall, based on the systemic signaling pathways and 
biological processes analysis of these six modules, 106 
significant seed mRNAs/proteins and the intersection 
sub-network itself, immune and inflammatory response, 
cell cycle, cell death or apoptosis and especially cancer-
related signaling pathways were highly associated with 
the effects of high urea concentration on the bladder 
urothelium. These data indicated that the changes in 
these signaling pathways and biological processes could 
be responsible for the pathological transition and lead 
to bladder disorders especially after persisting for a long 
time.
Diet protein amount regulated biological pathways 
in bladder urothelium
In order to further verify the effects of urinary urea con-
centration on biological processes in bladder urothelium, 
we carried out a long-term high-protein diet rat model 
in normal urine concentrating condition. After 40  days, 
urinary urea concentration was up to 1878  mmol/l in 
the HPD group that was twice higher than the normal-
protein diet group (958  mmol/l). The urinary osmo-
lality (2294  mOsm/kg H2O) was a little higher in the 
HPD group than that (1760  mOsm/kg H2O) in the 
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Fig. 3 Gene ontology (GO) biological processes of the intersection sub-network. Bubble diagram of the over-represented gene ontology biological 
processes of the intersection sub-network in bladder urothelium associating with high-protein diet was mapped using stats package in R environ-
ment
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normal-protein diet group in this model (Fig.  6a, b), 
which had no significant difference in statistics. Besides, 
there was no difference in the blood urea concentration 
between the two groups (Fig. 6c). The water consumption 
and urine output were much higher in HPD group than 
that in normal-diet group (Fig.  6d, e), indicating a high 
frequency of urination in the HPD group.
Hematoxylin and eosin (H and E) staining was adopted 
for morphologic analysis. As shown in Fig.  6f–i, after 
40 days of high urea concentration stimulation on blad-
der urothelium caused by high-protein diet, the blad-
ders showed interstitial congestion and inflammatory 
infiltrates under the urothelium in HPD group. Besides, 
endothelial cells desquamation, cytoplasm vacuolization, 
nucleus swelling and malformation also appeared in the 
HPD group.
Based on the analysis of the bioinformatics above, we 
concluded and tabled the significant mRNAs/proteins 
that obviously changed and were included in the immune 
and inflammatory response, cell cycle, apoptosis and 
especially cancer-related signaling pathways in Table  2. 
In the high-protein diet rat model, the qPCR results 
revealed that the mRNA expression of CRP, MCPT2, 
MCPT9, EPXH2, SERPING1 and SRGN, that were 
included in the immune and inflammatory response, 
was 1.88, 3.16, 3.20, 2.72, 0.22, 3.06 fold changed, respec-
tively (Fig. 7a). Especially, the activation of this biological 
process was demonstrated by immunohistochemistry of 
the macrophage marker F4/80. As seen in Fig. 8a, mac-
rophage infiltration was found under the bladder urothe-
lium in the HPD group. The mRNA expression of 
CDKN1C, CDK6, CCNB1, PCNA, BAX, involved in the 
regulation of cell cycle and apoptosis, was 2.44, 0.43, 
0.08, 0.43, 2.90 fold changed respectively (Fig.  7b). The 
cell cycle arrest and increased apoptosis were deter-
mined by the down-regulation of cyclin-dependent 
kinase (CCNB1/cyclin B1) and cyclin regulation protein 
(PCNA), and up-regulation of cyclin-dependent kinase 
inhibitor (CDKN1B/P27, a more representative protein 
than CDKN1C) and pro-apoptotic protein (BAX, Fig. 8a). 
Besides, the mRNA expression of MAGEB16, SERPINE1, 
HSPA2, FOS, involved in the cancer-related signaling 
Fig. 4 Functional modules identified by AllegroMCODE based on molecular complex detection (MCODE) algorithm. a–f Representative modules. 
Circle dots in the modules correspond to mRNAs/proteins. mRNAs/proteins in each module had similar biological functions: Module A was focused 
on ribosome biogenesis; module B was focused on pathways in cancer, T cell receptor signaling pathway, cell death and apoptosis; module C and D 
were focused on pathways in cancer; module E was focused on cell cycle; module F was focused on cell cycle and inflammation. Large sizes with red 
color stand for high degree connectivity, whereas small sizes with green color represent for low degree connectivity
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pathways, was 1.64, 2.83, 3.62, 2.54 fold changed respec-
tively (Fig.  7c). The protein expression of SERPINE1 
(PAI-1) and FOS (C-FOS) was also detected by immu-
nohistochemistry (Fig.  8a). The statistical results were 
shown on the right side of each picture in Fig. 8b.
Discussion
In the present study, we compared the two networks gen-
erated by the results of microarray and proteomics using 
Cytoscape. Gene ontology and pathway-based signaling 
regulator networks analysis revealed that immune and 
inflammatory response, cell cycle regulation, apoptosis, 
cell death and especially cancer-related signaling path-
ways were involved in the effects of high urea concentra-
tion on the bladder urothelium. These changed biological 
processes, which were further verified by qPCR, mor-
phological and immunohistochemical staining, might 
lead to an increased risk of bladder disorders and even 
carcinogenesis:
In the high-protein diet group, inflammatory response 
related biological processes were highly identified. CRP 
(c-reactive protein), a reliable and widely used marker 
of systemic inflammation, was up-regulated in HPD 
group. Previous studies showed that blood CRP concen-
tration was significantly higher in patients with urinary 
tract infection and interstitial cystitis [20, 21], which 
gained specific attentions in bladder dysfunction recently. 
Trichopoulos et  al. found an association between the 
increased plasma CRP level and the risk of developing 
urothelial tumors. MCTP2 and MCPT9 (Mast cell pro-
tease 2 and 9) were up-regulated in HPD group. Mast 
cells are thought to play an important role in surveillance 
and maintenance of the body and regulate crucial biolog-
ical process in innate and adaptive immunity [22]. Recent 
evidence indicated that MCPT2 and MCPT9 contributed 
to neutrophil recruitment and promoted the release of 
pro-inflammatory chemokines [23]. During most tumor 
initiation, these active inflammatory cells could induce 
the production or accumulation of reactive oxygen spe-
cies (ROS) and reactive nitrogen intermediates (RNI), 
which resulted in DNA damage and genomic instabil-
ity [24]. Another significant gene was EPHX2 (epoxide 
hydrolase 2) that was up-regulated in HPD group. Epox-
yeicosatrienoic acids (EETs), the products of cytochrome 
P-450 epoxygenase metabolism of arachidonic acid, 
had been shown to prevent the activation of NF-κB that 
in turn led to activation of downstream inflammatory 
cytokines [25, 26]. However, soluble epoxide hydrolase 
(sEH) could metabolize it to their much less active dihy-
droxy derivatives dihydroxyeicosatrienoic acids (DHETs) 
and performed its pro-inflammatory functions. Besides, 
SERPING1, a C1-inhibitor, was down-regulated in the 
Fig. 5 Gene ontology (GO) biological processes of the 106 significant mRNAs/proteins. The over-represented gene ontology biological processes of 
the 106 significant mRNAs/proteins in bladder urothelium associating with high-protein diet were analyzed using cytoscape plugin BINGO
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Fig. 6 Biological effect of long term high-protein diet in rats. a Urinary urea concentration. b Urinary osmolality. c Blood urea. d Water consump-
tion. e Urine output. f Representative magnification image of the bladder in control group. g High magnification image of box in f. h Representative 
magnification image of the bladder in HPD group. i High magnification image of box in h. Asterisk Interstitial congestion, inflammatory infiltrates, 
nucleus swelling and malformed. Arrows Endothelial cells thinned, desquamation, cytoplasm vacuolization
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HPD group. Broadly speaking, C1 inhibitor plays impor-
tant roles in a large amount of inflammatory diseases 
because of its suppression of inflammation through sev-
eral activities including suppressing complement system 
proteases (e.g.: C1r, C1s, MASP2), leukocyte infiltration 
and expression of pro-inflammatory cytokines. Moreo-
ver, SRGN, encoding serglycin, was also up-regulated 
in the HPD group. Previous studies demonstrated that 
serglycin played important functional roles in immune 
response, inflammation and even tumorigenesis. Serv-
ing as an ideal molecular partner for multiple molecular 
effectors, it could regulate the biosynthesis, secretion 
and targeted delivery of many inflammatory mediators 
including growth factors, cytokines, and chemokines to 
specific target sites. These functions turned to enhance 
inflammatory process and support tumor growth and 
metastasis [27].
It is now well elaborated that inflammatory microen-
vironment is highly associated with tumorigenesis. In 
this model, active inflammatory response were identi-
fied along with up-regulated of these pro-inflammatory 
mRNAs/proteins and down-regulated of anti-inflam-
matory ones, which revealed that inflammatory injury 
occurred in the rat bladder urothelium under the high 
urea concentration stress that would then increase the 
oncogenic mutation rates and raise the risk of bladder 
carcinogenesis.
The cell cycle is controlled by many regulators via a 
variety of mechanisms to ensure the alternation of each 
phase in order. It is now well established that cyclin-
dependent kinase (CDKs), cyclin-dependent kinase 
inhibitor (CKIs) and cyclin are the three main catego-
ries of these regulators. Cyclically accumulation and 
decomposition of cyclin play a positive regulation func-
tion in cell cycle progression, whereas CKIs play a neg-
ative regulation function through inhibiting the CDKs 
in the appropriate point of cell cycle. The balance of 
these regulators working synergistically with multiple 
factors promotes the smooth process of cell evolution 
[28–30].
Under the stress of high urinary urea concentration, the 
expression of CDKN1C (cyclin-dependent kinase inhibi-
tor 1C) was up-regulated in the bladder urothelium. On 
the contrary, the expression of CDK6, CCNB1 (a member 
of the highly conserved cyclin family) and PCNA (prolif-
erating cell nuclear antigen,) was down-regulated. PCNA 
is critical in DNA synthesis, repair and cell cycle regula-
tion and it is a good indicator reflecting the state of cell 
proliferation [31]. Recently, numerous evidences revealed 
a closely relationship between PCNA and tumorigen-
esis, development, metastasis, prognosis, etc. Besides, 
apoptosis-related protein BAX was increased in the HPD 
group. As a member of the Bcl-2 family proteins, BAX 
can promote apoptosis by translocating to the mitochon-
dria membrane from cytoplasm and forming oligomers 
and then leads to the release of cytochrome c that trig-
gers apoptosis.
The changes of these significant regulators in cell cycle 
and apoptosis-related proteins indicated that cell cycle 
arrest and increased apoptosis were induced by the stress 
of high urea concentration, which is consistent with the 
previous report that acute urea loading induced cell 
cycle delay and apoptosis [32]. These abnormal biological 
processes may lead to early injuries in urothelial cells or 
bladder disorders and hence increased the risk of bladder 
tumorigenesis.
Table 2 Highly identified biological processes and the corresponding genes/proteins
GO/pathway Gene symbol Microarray (fold change) Proteomics (fold change) Degree
Inflammatory response: CRP 1.281350 1.930480 16
MCPT2 2.780586 1.801877 0
MCPT9 3.310011 1.510910 0
EPHX2 1.513983 1.449821 5
SERPING1 0.513943 0.892042 9
SRGN 1.915938 1.123091 6
Cell cycle and apoptosis CDKN1C 1.682264 1.124969 10
CDK6 0.600723 0.977918 37
CCNB1 0.640989 0.920932 49
PCNA 0.897037 0.748792 127
BAX 1.520690 1.115530 33
Pathways in cancer MAGEB16 1.841369 1.219194 0
SERPINE1 2.245071 1.130098 15
HSPA2 1.740325 1.055071 27
FOS 1.524554 1.119582 72
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Moreover, lots of cancer-associated mRNAs/proteins 
changed, which revealed a deterioration of the develop-
ment tendency in the bladder urothelium. The most sig-
nificant ones were MAGEB16 (Melanoma-associated 
antigen B16), SERPINE1 (Plasminogen activator inhibitor 
1 RNA-binding protein, PAI-1), HSPA2 (Heat shock 70 
kDa protein 2) and FOS (Proto-oncogene C-FOS), which 
were all up-regulated in the HPD group.
Plasminogen activator inhibitor 1 RNA-binding pro-
tein, an important member of the plasminogen activa-
tor system, was found to be elevated in various cancers 
and its high levels in tumors usually coincided with poor 
prognosis. Although the contribution of PAI-1 to tumor 
angiogenesis had long been controversial, it was recently 
accepted that it could promote cancer cell proliferation 
and angiogenesis by inhibiting apoptosis in cell culture 
systems [33]. Villadsen et  al. found that miR-143/-145 
cluster, which directly targeted the PAI-1 3’UTR and 
reduced PAI-1 mRNA and protein levels, was down-reg-
ulated in all stages of bladder cancer and inversely corre-
lated with PAI-1 expression. So they suggested miR-145 
and PAI-1 as clinically relevant biomarkers of the bladder 
cancer [34]. HSPA2, whose abnormal expression is usu-
ally found in a subset of cancers, has also been identified 
as a potential tumor-promoting protein. ManojGarg et al. 
found that HSP70-2 was expressed in both high-grade 
invasive and moderate to well-differentiated urothelial 
carcinoma cell lines. Down-regulation of HSP70-2 could 
decrease cell growth, colony formation, invasion and 
migration of urothelial carcinoma cells, which makes it 
as a potential therapeutic target [35]. C-FOS, which has 
oncogenic activity and plays a significant role in prolif-
eration, differentiation, invasion, metastasis, and survival 
in tumor cells, is frequently over-expressed in many types 
of cancer [36]. Some studies also reported that C-FOS 
played an important role in arsenic-mediated carcino-
genesis of the urothelium [37, 38]. In addition, Li et  al. 
found that microRNA-490-5p inhibited the proliferation 
of bladder cancer by targeting the C-FOS 3’UTR and 
decreasing C-FOS expression at both mRNA and protein 
levels [39]. Overall, these mRNAs/proteins contained in 
the pathways in cancer were up-regulated and predicted 
a deterioration of the development tendency in the blad-
der urothelium.
Our previous work found that UT-B deletion in mice 
caused a marked urea accumulation in bladder urothelial 
cells, resulting in DNA damage and apoptosis. In accord-
ance with other research groups, they had reported that 
high urea concentration could affect protein stability by 
destroying hydrophobic bonds of protein structure or 
causing protein carbamylation and then changed multi-
ple biological activities [40, 41]. As the epidemiological 
studies showed that the incidence of bladder cancer was 
Fig. 7 mRNA expressions of related genes in the over-represented 
biological processes. a Relative mRNA levels of genes involved in 
immune and inflammatory response. b Relative mRNA levels of genes 
involved in cell cycle regulation, cell death and apoptosis. c Relative 
mRNA levels of genes involved in pathways in cancer. All data were 
determined by fluorescence based qPCR. Mean ± SEM., n = 6
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Fig. 8 Immunohistochemistry of representative proteins in the over-represented biological processes. a Representative immunohistochemis-
try (left) of the bladder urothelium from the two groups. Arrows F4/80 positive cells. b Bar graphs showing the positive cells or density ratios of 
the representative proteins to control group. 5 sections per mouse from 6 mice were quantitated and averaged by Image Pro Plus 6.0 software. 
Mean ± SEM., *P < 0.05, **P < 0.01 and ***P < 0.001
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the highest in the developed countries of Western Europe 
and higher in men than women [42], we considered this 
high incidence might be linked to high urinary urea con-
centration because of their high-level consumption of 
lean meat, milk, eggs or other high-protein food [43].
In physiological context, urea can be highly concen-
trated in urine up to more than 1000  mmol/l, however, 
it is usually less than 10 mmol/l in blood. Urothelial cells 
serve as a barrier between urine and blood. Under nor-
mal conditions, urea concentration is about 20.0 mmol/l 
in the urothelium [11]. In our high-protein diet models, 
it could be much higher than the normal value (That can 
be speculated by the increased urea concentration in uri-
nary), although we did not detect it because of the limited 
amount of sample and technical difficulty. Although this 
value is not seriously high, it could still create an imbal-
ance between the arginine-ornithine-polyamine pathway 
and the arginine-citrulline-NO pathway as discussed in 
our previous study and increase protein carbamoylation 
and carbonylation that is attributed to oxidative stress.
However, it should be noted that the limitations do 
exist in our present works: Firstly, the rats fed with dif-
ferent protein diets were just experimental models to 
study the people who eat high-protein food over a long 
period of time. The experimental period was too short to 
simulate people in some clinical characterizations. Nev-
ertheless, it revealed, to a certain extent, a relationship 
between high urea concentration and early injuries of 
urothelical cells or bladder disorders. Secondly, although 
urea was the major solute in urine under this condition 
and it could account for the bladder disorders directly, 
we could not exclude the possibilities of other indirect 
factors including the high osmolality itself. Thirdly, the 
main results in this study were based on the bioinformat-
ics techniques and verified only by qPCR, H.E. and IHC. 
More other epidemiological and experimental studies 
should be practiced in the future.
Conclusion
Our present work firstly elaborated the relation between 
the high-protein diet and the risk of bladder disor-
ders. It showed that abnormally activated inflammatory 
response, cell cycle arrest, apoptosis and pathways in 
cancer occurred in bladder urothelium under the stress 
of high urinary urea concentration, which provides us a 
new hint to associate the inducement of bladder disor-
ders and even carcinogenesis with high urinary urea con-
centration caused by high-protein diets.
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